Effects of hormonally active agents on steroid hormone receptor expression and cell proliferation in the myometrium of ovariectomized macaques

Toxicologic Pathology

Volumn 39, Issue 3, 2011, Pages 508-515

  Hill, Georgette D ^a   Moore, Alicia B ^b   Kissling, Grace E ^b   Flagler, Norris D ^b   Ney, Elizabeth ^b   Cline, J Mark ^c   Dixon, Darlene ^b,d  

^a INTEGRATED LABORATORY SYSTEMS   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

conjugated equine estrogens (CEE); Ki 67; macaques; medroxyprogesterone acetate (MPA); myometrium; steroid receptors; tamoxifen (TAM)

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MACACA; MYOMETRIUM; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REPRODUCTIVE TOXICITY; SMOOTH MUSCLE FIBER;

ANIMALS; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS, CONJUGATED (USP); FEMALE; HORMONE REPLACEMENT THERAPY; KI-67 ANTIGEN; MACACA FASCICULARIS; MEDROXYPROGESTERONE ACETATE; MYOMETRIUM; OVARIECTOMY; RECEPTORS, PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

ANIMALIA; EQUIDAE; MACACA;

EID: 79955553422     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311401045     Document Type: Article

References (49)

1. Adams M. R., Register T. C., Golden D. L., Wagner J. D., Williams J. K.. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 1997 ; 17: 217-21 (Pubitemid 27057346)
2. Andersen J.. Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium. Environ Health Perspect. 2000 ; 108: 811-15
3. Baskin G. B., Smith S. M., Marx P. A.. Endometrial hyperplasia, polyps, and adenomyosis associated with unopposed estrogen in rhesus monkeys (Macaca mulatta). Vet Pathol. 2002 ; 39: 572-75
4. Bergman L., Beelen M. L., Gallee M. P., Hollema H., Benraadt J., van Leeuwen F. E.. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet. 2000 ; 356: 881-87
5. Botsis D., Koliopoulos C., Kondi-Pafitis A., Creatsas G.. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: A case report. Int J Gynecol Pathol. 2006 ; 25: 173-75 (Pubitemid 44620181)
6. Buttram V. C., Reiter R. C.. Uterine leiomyomata: Etiology, symptomatology, and management. Fertil Steril. 1981 ; 36: 443-45
7. Cattoretti G., Becker M. H., Key G., Duchrow M., Schluter C., Galle J., Gerdes J.. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992 ; 168: 357-63 (Pubitemid 23013251)
8. Cline J. M., Soderqvist G., Register T. C., Williams J. K., Adams M. R., Von Schoultz B.. Assessment of hormonally active agents in the reproductive tract of female nonhuman primates. Toxicol Pathol. 2001 ; 29: 84-90 (Pubitemid 32127326)
9. Cline J. M., Soderqvist G., von Schoultz E., Skoog L., von Schoultz B.. Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques. Breast Cancer Res Treat. 1998 ; 48: 221-29 (Pubitemid 28159950)
10. Cohen I., Azaria R., Fishman A., Tepper R., Shapira J., Beyth Y.. Endometrial cancers in postmenopausal breast cancer patients with tamoxifen treatment. Int J Gynecol Pathol. 1999 ; 18: 304-9 (Pubitemid 29489050)
11. Curtis S. W., Shi H., Teng C., Korach K. S.. Promoter and species specific differential estrogen-mediated gene transcription in the uterus and cultured cells using structurally altered agonists. J Mol Endocrinol. 1997 ; 18: 203-11 (Pubitemid 27278394)
12. Daniel Y., Inbar M., Bar-Am A., Peyser M. R., Lessing J. B.. The effects of tamoxifen treatment on the endometrium. Fertil Steril. 1996 ; 65: 1083-89 (Pubitemid 26158621)
13. Deligdisch L.. Hormonal pathology of the endometrium. Mod Pathol. 2000 ; 13: 285-94 (Pubitemid 30207513)
14. Deroo B. J., Korach K. S.. Estrogen receptors and human disease. J Clin Invest. 2006 ; 116: 561-70 (Pubitemid 43326860)
15. Detre S., Saclani Jotti G., Dowsett M.. A "quickscore" method for immunohistochemical semiquantitation: Validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995 ; 48: 876-78
16. Dixon D., He H., Haseman J. K.. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Perspect. 2000 ; 5: 795-802
17. Eckert R. L., Katzenellenbogen B. S.. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res. 1982 ; 42: 139-44 (Pubitemid 12207261)
18. Ennis B. W., Stumpf W. E.. Differential induction of progestin-binding sites in uterine cell types by estrogen and antiestrogen. Endocrinology. 1988 ; 123: 1747-53
19. Flake G. P., Andersen J., Dixon D.. Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect. 2003 ; 111: 1037-54 (Pubitemid 36826884)
20. Flouriot G., Griffin C., Kenealy M., Sonntag-Buck V., Gannon F.. Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol Endocrinol. 1998 ; 12: 1939-54 (Pubitemid 28544188)
21. Gielen S. C., Kuhne L. C., Ewing P. C., Blok L. J., Burger C. W.. Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: An exploratory study. Endocr Relat Cancer. 2005 ; 12: 1037-49 (Pubitemid 41815795)
22. Graham J. D., Clarke C. L.. Physiological action of progesterone in target tissues. Endocr Rev. 1997 ; 18: 502-19 (Pubitemid 27349554)
23. Habiba M. A., Bell S. C., Al-Azzawi F.. The effect of hormone replacement therapy on the immunoreactive concentrations in the endometrium of oestrogen and progesterone receptor, heat shock protein 27, and human β- lactoglobulin. Hum Reprod. 2000 ; 15: 36-42
24. Hanifi-Moghaddam P., Boers-Sijmons B., Klaassens A. H., van Wijk F. H., Van Ijcken W. F., Van der Spek P., Verheul H. A., Kloosterboer H. J., Burger C. W., Blok L. J.. Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vagina. Hum Reprod. 2008 ; 23: 298-305 (Pubitemid 351651244)
25. Hertelendy F., Zakar T.. Regulation of myometrial smooth muscle functions. Curr Pharm Des. 2004 ; 10: 2499-2517 (Pubitemid 38997430)
26. Isaksson E., Wang H., Sahlin L., von Schoultz B., Cline J. M., von Schoultz E.. Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques. Breast Cancer Res Treat. 2003 ; 79: 233-39 (Pubitemid 36649173)
27. Ismail M. T.. A prospective study of a monophasic oral contraceptive containing 30 mcg ethinyl oestradiol and 150 mcg desogestrel (Marvelon). Malays J Reprod Health. 1994 ; 12: 43-48
28. Kennedy M. M., Baigrie C. F., Manek S.. Tamoxifen and the endometrium: Review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology. Int J Gynecol Pathol. 1999 ; 18: 130-37 (Pubitemid 29153279)
29. Kiley J., Hammond C.. Combined oral contraceptives: A comprehensive review. Clin Obstet Gynecol. 2007 ; 50: 868-77 (Pubitemid 350059283)
30. Kuiper G. G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J. A.. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997 ; 138: 863-70 (Pubitemid 27089735)
31. Lacey J. V., Brinton L. A., Lubin J. H., Sherman M. E., Schatzkin A., Schairer C.. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005 ; 14: 1724-31 (Pubitemid 40995086)
32. Marshall L. M., Spiegelman D., Goldman M. B., Manson J. E., Colditz G. A., Barbieri R. L., Stampfer M. J., Hunter D. J.. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 1998 ; 70: 432-39 (Pubitemid 28435626)
33. McCluggage W. G., Varma M., Weir P., Bharucha H.. Uterine leiomyosarcoma in patient receiving tamoxifen therapy. Acta Obstet Gynecol Scand. 1996 ; 75: 593-95 (Pubitemid 26242590)
34. Mourits M. J. E., Ten Hoor K. A., van der Zee A. G. J., Willemse P. H. B., de Vries E. G. E., Hollema H.. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol. 2002 ; 55: 514-19 (Pubitemid 34779303)
35. Nephew K. P., Long X., Osborne E., Burke K. A., Ahluwalia A., Bigsby R. M.. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol Reprod. 2000 ; 62: 168-77 (Pubitemid 30013483)
36. Polatti F., Viazzo F., Colleoni R., Nappi R. E.. Uterine myoma in postmenopause: A comparison between two therapeutic schedules of HRT. Maturitas. 2000 ; 37: 27-32
37. Sahlin L., Masironi B., Akerberg S., Eriksson H.. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus. Reprod Biol Endocrinol. 2006 ; 4 :
38. Sakaguchi H., Fujimoto J., Aoki I., Tamaya T.. Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids. 2003 ; 68: 11-19 (Pubitemid 35418301)
39. Swerdlow A. J., Jones M. E.. Tamoxifen treatment for breast cancer and risk of endometrial cancer: A case-control study. J Natl Cancer Inst. 2005 ; 97: 375-84 (Pubitemid 40425956)
40. Ugwumadu A. H., Harding K.. Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen. Eur J Obstet Gynecol Reprod Biol. 1994 ; 54: 153-56 (Pubitemid 24170237)
41. Uno H.. Age-related pathology and biosenescent markers in captive rhesus macaques. Age. 1997 ; 20: 1-13
42. Hormone therapy for the prevention of chronic conditions in postmenopausal women: Recommendations from the U. S. Preventive Services Task Force. Ann Intern Med. 2005 ; 142: 855-60
43. Varayoud J., Ramos J. G., Monje L., Bosquiazzo V., Munoz-de-Toro M., Luque E. H.. The estrogen receptor alpha sigma3 mRNA splicing variant is differentially regulated by estrogen and progesterone in the rat uterus. J Endocrinol. 2005 ; 186: 51-60 (Pubitemid 41015663)
44. Vereide A. B., Kaino T., Sager G., Arnes M., Orbo A.. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia. Gynecol Oncol. 2006 ; 101: 214-23
45. Wang H., Isaksson E., Von Schoultz B., Cline J. M., Sahlin L.. The effect of long-term treatment with steroid hormones or tamoxifen on oestrogen receptors (alpha and beta) in the endometrium of ovariectomized cynomolgus macaques. J Endocrinol. 2002 ; 175: 673-81 (Pubitemid 36061172)
46. Wang H., Isaksson E., Von Schoultz B., Cline J. M., Sahlin L.. Effect of long-term treatment with steroid hormones or tamoxifen on the progesterone receptor and androgen receptor in the endometrium of ovariectomized cynomolgus macaques. Reprod Biol Endocrinol. 2003 ; 1 :
47. Williams J. K., Wagner J. D., Li Z., Golden D. L., Adams M. R.. Arterioscler Thromb Vasc Biol. 1997 ; 17: 403-8
48. Wood C. E., Register T. C., Anthony M. S., Kock N. D., Cline J. M.. Breast and uterine effects of soy isoflavones and conjugated equine estrogens in postmenopausal female monkeys. J Clin Endocrinol Metab. 2004 ; 89: 3462-68 (Pubitemid 38951921)
49. Ylostalo P., Granberg S., Backstrom A. C., Hirsjarvi-Lahti T.. Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women. Maturitas. 1996 ; 23: 313-17 (Pubitemid 26000613)